RSV Infections on the Rise, According to RKI
As the colder months approach, the Robert Koch Institute (RKI) reports an uptick in respiratory syncytial virus (RSV) infections across Germany. Less fortunately, children under two years old have been the most affected, necessitating hospitalization in severe cases where ventilation might be required.
The RKI recently revealed that the RSV wave had started, retrospectively dating it to the week beginning November 20. In the current report on acute respiratory diseases, RSV cases have surged, causing concerns among medical professionals and parents alike.
While RSV typically results in symptoms such as a runny nose, loss of appetite, and throat inflammation, it can lead to potentially severe consequences like pneumonia and the need for ventilation in some extreme cases. The Federal Center for Health Education notes that coughing, sneezing, and high fever often follow.
Although RSV affects various age groups, certain individuals are considered at higher risk, including:
- Premature babies
- Children with pre-existing lung diseases or heart defects
- Adults over 65 years of age
- People with an impaired immune system
Experts now expect a more typical wave of RSV infections this winter, as the country moves beyond the harsher wave triggered by the coronavirus pandemic and measures enacted to contain its spread.
To help prevent the spread of not just RSV but also coronavirus and rhinoviruses, health organizations worldwide – such as the Centers for Disease Control and Prevention (CDC) – recommend these strategies:
- Regular hand washing
- Maintaining social distance
- Wearing masks (especially in high-risk settings)
- Surface cleaning
- Regularly consulting medical professionals for cold-like symptoms that do not improve or worsen.
For more detailed information on prevention and treatment, visit the CDC website or consult your local health authority. Stay informed and take the necessary steps to keep yourself and your loved ones protected during the upcoming RSV season and beyond.